In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST

BACKGROUND AND PURPOSE: Candida glabrata is the second cause of candidiasis. The mortality rate of C. glabrata infections is about 40%; accordingly, it may be life threatening, especially in immunocompromised hosts. Regarding this, the current study was conducted to evaluate the regional patterns of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatahinia, Mahnaz, Halvaeizadeh, Marzieh, Zarei Mahmoudabadi, Ali, AboualiGalehdari, Elham, Kiasat, Neda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Medical Mycology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888517/
https://www.ncbi.nlm.nih.gov/pubmed/33628974
http://dx.doi.org/10.18502/CMM.6.2.2692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888517/
https://www.ncbi.nlm.nih.gov/pubmed/33628974
http://dx.doi.org/10.18502/CMM.6.2.2692

Ejemplares similares